Search results
Showing 151 to 165 of 181 results for nice conference
implementation of all NICE guidance? No Does the example relate to a specific implementation of a specific piece of NICE...
This quality standard covers services for domestic violence and abuse in adults and young people (aged 16 and over). It includes identifying and supporting people experiencing domestic violence or abuse, as well as support for those who carry it out. It also covers children and young people (under 16) who are affected by domestic violence or abuse that is not carried out against them. It describes high-quality care in priority areas for improvement.
View quality statements for QS116Show all sections
Sections for QS116
- Introduction
- List of quality statements
- Quality statement 1: Asking about domestic violence and abuse
- Quality statement 2: Response to domestic violence and abuse
- Quality statement 3: Referral to specialist support services for people experiencing domestic violence or abuse
- Quality statement 4: Referral to specialist services for people perpetrating domestic violence or abuse
- Using the quality standard
- Diversity, equality and language
High-throughput non-invasive prenatal testing for fetal RHD genotype (DG25)
Evidence-based recommendations on high-throughput non-invasive prenatal testing (NIPT) for fetal RHD genotype
Clostridium difficile infection: risk with broad-spectrum antibiotics (ESMPB1)
Summary of the evidence on the risk of using broad-specturm antibiotics associated with clostridium difficile infection
This example describes the use of NICE Quality Standard QS50 to guide training for staff in homes and act as framework
Improving awareness of Familial Hypercholesterolaemia in primary care
The Wales Familial Hypercholesterolaemia (FH) service, based around NICE CG71, aims to provide an equitable opportunity for the people...
NICE has developed a medtech innovation briefing (MIB) on digital technologies for the detection of melanoma .
NICE has developed a medtech innovation briefing (MIB) on plasma EGFR mutation tests for adults with locally advanced or metastatic non-small-cell lung cancer .
The NICE public health guidance development process (third edition) (PMG5)
The NICE public health guidance development process (third edition)
Show all sections
- 1 Introduction
- 2 Topic selection
- 3 The guidance development processes
- 4 The role of stakeholders in the guidance development process
- 5 The role of the Public Health Advisory Committees (PHACs) in the development of public health guidance
- 6 The role of evidence providers
- 7 The role of the CPHE project team
- 8 Fieldwork
Early value assessment (EVA) guidance on guided self-help digital cognitive behavioural therapy for children and young people with mild to moderate symptoms of ...
NICE has developed a Medtech Innovation Briefing (MIB) on the SpyGlass direct visualisation system for diagnostic and therapeutic procedures during endoscopy of
Refer-to-Pharmacy (R2P) is THE tool that let's hospitals meet one of the requirements of NICE's NG5 Medicines Optimisation guidance...
. Each appeal panel consists of 5 members, 4 of whom are independent of NICE. An external member will chair the appeal panel. This chair...
Management Programme Board. This was in parallel to the publication of the NICE Guideline (NG5) Medicines Optimisation: the safe and...
Novii Wireless Patch System for maternal and fetal monitoring (MIB228)
NICE has developed a medtech innovation briefing (MIB) on Novii Wireless Patch System for maternal and fetal monitoring .